Pfizer And Omeros Corporation: PDE10 Inhibitors
- Pfizer is a relatively safe pharmaceutical stock; Omeros Corporation is risky.
- Both companies have replied to questioning on PDE10 inhibitors.
- Per available information, Omeros Corporation has the premier product candidate known.
- Still, hedging an investment in PFE, or bet against OMER, could ultimately make sense.